The application value by18F-FDG PET/CT imaging in thyroid lesions
Ming NI,Shicun WANG,Xin LIU,Yifan ZHANG,Bo PAN,Fenglin ZHAN
2019-01-01
Journal of Medical Imaging
Abstract:Objective To initially investigate the value of 18F-FDG PET/CT imaging in the evaluation of thyroid lesions. Methods The data of 18 patients with thyroid lesions and pathological results were analyzed retrospectively, who were found with such lesions in inspection from October 2014 to Dctober 2017. Patients with normal thyroid or peripheral blood pool on same side were taken as the healthy control group, and the analysis was made on the SUVmax of the malignant lesion group, the benign lesion group and the healthy control group, and on the ROC curve of SUVmax of benign and malignant thyroid lesions. The CT morphology and density of the lesions were observed. The comprehensive analysis and computation were also made on the value of PET, PET/CT in the diagnosis of thyroid lesions. Results 1) There were 21 lesions (including 14 malignant lesions and 7 benign lesions) in 21 patients. SUVmax of thyroid malignant group, benign lesion group and healthy control group were 10.12±9.42, 5.47±2.97, and 1.43±0.38, respectively. There was no significant difference in SUVmax between thyroid malignant group and benign lesion group (F=0.635, and P=0.435), and there was a significant difference in SUVmax between thyroid malignant group, benign lesion group and healthy control group (F=10.748 and 18.270, P<0.01); 2) Analysis of SUVmax ROC of thyroid benign and malignant lesions was AUC 0.515 (<0.70), so the diagnostic accuracy was low; 3) The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 18F-FDG PET for the differentiation of thyroid benign and malignant lesions were 71.43％ (10/14), 42.86％ (3/7), 71.43％ (10/14), 42.86％ (3/7), and 61.90％ (13/21), respectively. The diagnostic value of 18F-FDG PET/CT was 92.86％ (13/14), 71.43％ (5/7), 86.67％ (13/15), 83.33％ (5/6), 85. 71％ (18/21), respectively.18F-FDG PET was very poorly consistent with the standard group in diagnostic value of benign and malignant lesions (Kappa = 0. 143, μ = 0. 644, P = 0. 513), while18F-FDG PET/CT was basically consistent with the standard group (Kappa = 0. 762, μ = 4. 792, P < 0. 01). Conclusion SUVmax in 18F-FDG PET/CT imaging cannot be used as a diagnostic parameter of benign and malignant thyroid disease. The combination of PET metabolic characteristics and CT morphological changes can initially identify the nature of thyroid lesions, and provide more clinical information such as the metastasis or concurrent with other benign and malignant diseases.